United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
Full Year 2024 Results Key Financial Results Revenue: €147.4m (down 39% from FY 2023).
15hon MSN
We recently published a list of Was Jim Cramer’s Call Right on These 10 Stocks? In this article, we are going to take a look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback